Ultragenyx Pharmaceutical Inc. (RARE)
USD 31.01
(-4.38%)
USD 31.01
(-4.38%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -569.2 Million USD | 12.28% |
| 2022 | -648.91 Million USD | -69.99% |
| 2021 | -381.73 Million USD | -15.64% |
| 2020 | -330.11 Million USD | 22.17% |
| 2019 | -424.17 Million USD | -14.22% |
| 2018 | -371.37 Million USD | -12.9% |
| 2017 | -328.94 Million USD | -32.63% |
| 2016 | -248 Million USD | -67.87% |
| 2015 | -147.73 Million USD | -160.2% |
| 2014 | -56.77 Million USD | -75.89% |
| 2013 | -32.28 Million USD | -101.94% |
| 2012 | -15.98 Million USD | -143.64% |
| 2011 | -6.56 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -116.36 Million USD | 29.63% |
| 2024 Q1 | -165.34 Million USD | -35.48% |
| 2023 FY | -569.2 Million USD | 12.28% |
| 2023 Q3 | -145.09 Million USD | 1.93% |
| 2023 Q1 | -154.1 Million USD | -5.82% |
| 2023 Q2 | -147.95 Million USD | 3.99% |
| 2023 Q4 | -122.04 Million USD | 15.88% |
| 2022 Q3 | -225.06 Million USD | -58.95% |
| 2022 Q4 | -145.62 Million USD | 35.3% |
| 2022 FY | -648.91 Million USD | -69.99% |
| 2022 Q1 | -136.63 Million USD | -33.22% |
| 2022 Q2 | -141.59 Million USD | -3.63% |
| 2021 Q4 | -102.56 Million USD | -14.18% |
| 2021 FY | -381.73 Million USD | -15.64% |
| 2021 Q1 | -106.56 Million USD | -10.92% |
| 2021 Q2 | -82.77 Million USD | 22.33% |
| 2021 Q3 | -89.82 Million USD | -8.52% |
| 2020 Q2 | -63.05 Million USD | 47.74% |
| 2020 Q4 | -96.08 Million USD | -90.96% |
| 2020 Q1 | -120.66 Million USD | -27.75% |
| 2020 FY | -330.11 Million USD | 22.17% |
| 2020 Q3 | -50.31 Million USD | 20.2% |
| 2019 Q2 | -112.47 Million USD | -13.37% |
| 2019 FY | -424.17 Million USD | -14.22% |
| 2019 Q1 | -99.21 Million USD | -9.82% |
| 2019 Q4 | -94.45 Million USD | 19.98% |
| 2019 Q3 | -118.03 Million USD | -4.94% |
| 2018 Q3 | -89.64 Million USD | 5.54% |
| 2018 FY | -371.37 Million USD | -12.9% |
| 2018 Q1 | -96.48 Million USD | 0.36% |
| 2018 Q2 | -94.9 Million USD | 1.64% |
| 2018 Q4 | -90.34 Million USD | -0.77% |
| 2017 FY | -328.94 Million USD | -32.63% |
| 2017 Q1 | -69.95 Million USD | 0.84% |
| 2017 Q2 | -78.44 Million USD | -12.13% |
| 2017 Q3 | -83.71 Million USD | -6.72% |
| 2017 Q4 | -96.83 Million USD | -15.67% |
| 2016 Q1 | -53.62 Million USD | 4.52% |
| 2016 Q4 | -70.54 Million USD | -7.25% |
| 2016 Q3 | -65.78 Million USD | -13.32% |
| 2016 Q2 | -58.05 Million USD | -8.26% |
| 2016 FY | -248 Million USD | -67.87% |
| 2015 Q3 | -39.93 Million USD | -32.49% |
| 2015 Q2 | -30.14 Million USD | -40.18% |
| 2015 Q1 | -21.5 Million USD | -26.91% |
| 2015 FY | -147.73 Million USD | -160.2% |
| 2015 Q4 | -56.15 Million USD | -40.62% |
| 2014 Q1 | -10.33 Million USD | -8.55% |
| 2014 Q4 | -16.94 Million USD | -7.0% |
| 2014 Q3 | -15.83 Million USD | -15.91% |
| 2014 Q2 | -13.66 Million USD | -32.13% |
| 2014 FY | -56.77 Million USD | -75.89% |
| 2013 Q1 | -6.74 Million USD | -44.23% |
| 2013 Q3 | -7.76 Million USD | 5.89% |
| 2013 Q4 | -9.52 Million USD | -22.73% |
| 2013 FY | -32.28 Million USD | -101.94% |
| 2013 Q2 | -8.24 Million USD | -22.23% |
| 2012 Q4 | -4.67 Million USD | 0.0% |
| 2012 FY | -15.98 Million USD | -143.64% |
| 2011 FY | -6.56 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -139.963% |
| Alkermes plc | 414.12 Million USD | 237.449% |
| Agenus Inc. | -159.54 Million USD | -256.761% |
| Aptorum Group Limited | -10.52 Million USD | -5309.01% |
| Ardelyx, Inc. | -63.27 Million USD | -799.564% |
| Dyadic International, Inc. | -8.22 Million USD | -6816.477% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -47652.349% |
| Lantern Pharma Inc. | -17.87 Million USD | -3083.923% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2733.32% |
| Novavax, Inc. | -566.51 Million USD | -0.476% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -679.961% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -592.501% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2831.264% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -5288.696% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -971.422% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -49.596% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2241.783% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1403.098% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -341.288% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -578.323% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -3145.385% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1193.361% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -2191.129% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -309.411% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -101.722% |
| AlloVir, Inc. | -181.33 Million USD | -213.906% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -177.66% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1845.478% |
| Bicycle Therapeutics plc | -189.94 Million USD | -199.668% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -231.355% |
| ChromaDex Corporation | -5.59 Million USD | -10066.244% |
| Chimerix, Inc. | -93.06 Million USD | -511.624% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1162.738% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -390.447% |
| CRISPR Therapeutics AG | -222.53 Million USD | -155.78% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1201.463% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -198.78% |
| Fortress Biotech, Inc. | -142.34 Million USD | -299.888% |
| Fortress Biotech, Inc. | -142.34 Million USD | -299.888% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -482.644% |
| ImmuCell Corporation | -5.74 Million USD | -9802.58% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -323.426% |
| Immix Biopharma, Inc. | -16.14 Million USD | -3426.448% |
| Incyte Corporation | 620.52 Million USD | 191.73% |
| Innoviva, Inc. | 176.7 Million USD | 422.116% |
| IO Biotech, Inc. | -91.44 Million USD | -522.473% |
| Jaguar Health, Inc. | -34.29 Million USD | -1559.934% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -234.944% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4866.438% |
| ContextLogic Inc. | -328 Million USD | -73.539% |
| MiMedx Group, Inc. | 37.11 Million USD | 1633.592% |
| MEI Pharma, Inc. | 14.54 Million USD | 4014.235% |
| NextCure, Inc. | -67.63 Million USD | -741.563% |
| Onconetix, Inc. | -36.03 Million USD | -1479.615% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1264.549% |
| Opthea Limited | -191.84 Million USD | -196.706% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -20584.746% |
| Vaxcyte, Inc. | -468.04 Million USD | -21.615% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1222.348% |
| Precigen, Inc. | -88.92 Million USD | -540.113% |
| Pharming Group N.V. | -4.87 Million USD | -11565.188% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -240.208% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1812.918% |
| PureTech Health plc | -146.19 Million USD | -289.338% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2677.844% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -141.601% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2241.783% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -107.736% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1842.358% |
| Acelyrin, Inc. | -422.06 Million USD | -34.863% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -4414096.576% |
| Summit Therapeutics Inc. | -89.73 Million USD | -534.314% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1435.744% |
| Senti Biosciences, Inc. | -92.72 Million USD | -513.854% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -395.942% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1152.521% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1561.097% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -14339.398% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -17901.518% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1623.776% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6595.777% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -737.12% |
| Seer, Inc. | -103.46 Million USD | -450.156% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -765.597% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -691.303% |
| ESSA Pharma Inc. | -32.13 Million USD | -1671.352% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1349.278% |
| GT Biopharma, Inc. | -13.57 Million USD | -4092.752% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -159.65% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -1130.56% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 755.679% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -902.851% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -1005.129% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -5627.796% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -12.868% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -8151.783% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -1022.853% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -119.214% |
| Aptose Biosciences Inc. | -52.35 Million USD | -987.188% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3847.139% |
| Soligenix, Inc. | -7.69 Million USD | -7294.29% |
| Century Therapeutics, Inc. | -146.54 Million USD | -288.416% |
| Kura Oncology, Inc. | -165.8 Million USD | -243.302% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -509.052% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -6742.265% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -22836.777% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -8678.655% |
| Autolus Therapeutics plc | -195.02 Million USD | -191.86% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -572.37% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -672.729% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2593.201% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -150.714% |
| GRI Bio, Inc. | -11.38 Million USD | -4898.753% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -12505.047% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -333.871% |
| IGM Biosciences, Inc. | -263.46 Million USD | -116.05% |
| INmune Bio, Inc. | -29.74 Million USD | -1813.883% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -414.585% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1394.953% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3462.145% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -3509.246% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -831.631% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -429.387% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -106.23% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -180.123% |
| Verastem, Inc. | -92.08 Million USD | -518.14% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -1107.612% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -209.109% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -380.831% |
| Histogen Inc. | -10.64 Million USD | -5248.191% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3578.965% |
| Surrozen, Inc. | -45.78 Million USD | -1143.355% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3673.088% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -11082.35% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -860.179% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -1009.697% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -2151.614% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -7357.352% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -232.32% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -1074.886% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -627.841% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3639.678% |
| Apollomics, Inc. | -54.83 Million USD | -938.057% |
| Amarin Corporation plc | -67.58 Million USD | -742.173% |
| Mesoblast Limited | -58.79 Million USD | -868.14% |
| Turnstone Biologics Corp. | -59.03 Million USD | -864.236% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -243.87% |
| Synaptogenix, Inc. | -8.31 Million USD | -6746.5% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3802.427% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -520.789% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11779.621% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -6345.395% |
| Exelixis, Inc. | 170.88 Million USD | 433.094% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1387.659% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -267.082% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -10.072% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4720.911% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -6978.024% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1797.803% |
| Gritstone bio, Inc. | -154.63 Million USD | -268.1% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -726.604% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -3224.22% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2947.478% |
| Insmed Incorporated | -709.62 Million USD | 19.788% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3527.888% |
| MediWound Ltd. | -15.29 Million USD | -3622.747% |
| OmniAb, Inc. | -69.41 Million USD | -719.96% |
| Alector, Inc. | -151.74 Million USD | -275.121% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -427.127% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -991.524% |
| Zai Lab Limited | -366.57 Million USD | -55.278% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -79.687% |
| Aura Biosciences, Inc. | -84.99 Million USD | -569.727% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -131.858% |
| Immunic, Inc. | -99.22 Million USD | -473.665% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -297.608% |
| Veracyte, Inc. | -85.79 Million USD | -563.451% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -101.979% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3905.686% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -8163.827% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2928.892% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 198.38% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -2136.31% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1566.955% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2858.726% |
| Galecto, Inc. | -39.9 Million USD | -1326.408% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1252.874% |
| Fortrea Holdings Inc. | 63.1 Million USD | 1002.073% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -305.289% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1871.078% |
| XBiotech Inc. | -37.51 Million USD | -1417.483% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -726.604% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -748.045% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -427.504% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2117.233% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -968.093% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -625.18% |
| Vaxxinity, Inc. | -58.28 Million USD | -876.594% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -448.851% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2457.878% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -558.684% |
| NexImmune, Inc. | -29.19 Million USD | -1849.845% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -10028.018% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3803.664% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 114.065% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -2135.783% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4758.847% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -347.977% |
| Ainos, Inc. | -13.2 Million USD | -4210.093% |
| Pluri Inc. | -22.15 Million USD | -2468.86% |
| Prothena Corporation plc | -191.03 Million USD | -197.958% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -312.356% |
| Celularity Inc. | -192.28 Million USD | -196.02% |
| Rallybio Corporation | -78.93 Million USD | -621.137% |
| Cue Biopharma, Inc. | -52.14 Million USD | -991.503% |
| MeiraGTx Holdings plc | -137.06 Million USD | -315.295% |
| Omeros Corporation | -164.53 Million USD | -245.96% |
| Humacyte, Inc. | -100.04 Million USD | -468.941% |
| Immunocore Holdings plc | -59.64 Million USD | -854.262% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2967.019% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -2224.911% |
| Blueprint Medicines Corporation | -486.27 Million USD | -17.054% |
| CalciMedica, Inc. | -21.87 Million USD | -2502.094% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -662.4% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -332.907% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -232.297% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -74.123% |
| Pulmatrix, Inc. | -14.74 Million USD | -3761.655% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1492.413% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -540.524% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -10.463% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -742.634% |
| Cytokinetics, Incorporated | -496.2 Million USD | -14.712% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1553.761% |
| Nutriband Inc. | -4.87 Million USD | -11583.429% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1205.134% |
| Vor Biopharma Inc. | -126.03 Million USD | -351.623% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 113.418% |
| Evogene Ltd. | -26.39 Million USD | -2056.826% |
| ProKidney Corp. | -151.52 Million USD | -275.66% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -782.014% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -7299.767% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 6.283% |
| CorMedix Inc. | -48.95 Million USD | -1062.651% |
| BioLineRx Ltd. | -49.69 Million USD | -1045.426% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -398.549% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1395.083% |
| Atai Life Sciences N.V. | -125.47 Million USD | -353.657% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -597.223% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -599.195% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -128.609% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1751.685% |
| MediciNova, Inc. | -9.9 Million USD | -5649.422% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -350.419% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7759.32% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2028.442% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -145.533% |
| Biomea Fusion, Inc. | -126.13 Million USD | -351.269% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -62.909% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1903.125% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -197.876% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -147.531% |
| Absci Corporation | -115.51 Million USD | -392.757% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1963.32% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -404.317% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -135.053% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -2159.12% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -173.666% |
| Allakos Inc. | -196.05 Million USD | -190.329% |
| Imunon, Inc. | -21.03 Million USD | -2606.592% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -414.357% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 630.572% |
| BioAtla, Inc. | -129.68 Million USD | -338.909% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4720.911% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -3492.804% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -73.678% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1263.111% |
| XOMA Corporation | -41.84 Million USD | -1260.18% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -440.882% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -368.503% |
| aTyr Pharma, Inc. | -54.91 Million USD | -936.45% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -551.067% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -229.269% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -123.701% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2551.672% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -6830.78% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3286.933% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -6436698.247% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 268.617% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -8611.449% |
| UroGen Pharma Ltd. | -65.53 Million USD | -768.542% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -537.568% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -7737.079% |
| Orgenesis Inc. | -53.63 Million USD | -961.242% |
| Entera Bio Ltd. | -8.89 Million USD | -6302.07% |
| GH Research PLC | -41.22 Million USD | -1280.835% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -2114.128% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -585.355% |
| Xencor, Inc. | -138.63 Million USD | -310.568% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -10942.756% |
| Replimune Group, Inc. | -234.77 Million USD | -142.45% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2548.573% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3979.759% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -8611.449% |
| Portage Biotech Inc. | -18.25 Million USD | -3018.435% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7759.32% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -442.304% |
| OncoCyte Corporation | -25.13 Million USD | -2164.513% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4935.075% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4868.185% |
| Purple Biotech Ltd. | 22.27 Million USD | 2655.826% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -7477.316% |
| scPharmaceuticals Inc. | -55.39 Million USD | -927.525% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2912.05% |
| HilleVax, Inc. | -133.34 Million USD | -326.869% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -4624.11% |
| Tharimmune, Inc. | -9.45 Million USD | -5920.04% |
| Genprex, Inc. | -31.07 Million USD | -1731.69% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -202.458% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1714.093% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -74306.275% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -10350.091% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3613981.003% |
| Savara Inc. | -60 Million USD | -848.569% |
| Curis, Inc. | -48.33 Million USD | -1077.704% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1745.688% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -10810.053% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -7722.015% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1988.837% |
| BeiGene, Ltd. | -1.2 Billion USD | 52.87% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2754.704% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -16.836% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -507.791% |
| Erasca, Inc. | -141.52 Million USD | -302.196% |
| bluebird bio, Inc. | -244.26 Million USD | -133.032% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -12473.697% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 392.741% |
| DBV Technologies S.A. | -76.43 Million USD | -644.725% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -12473.697% |
| Moderna, Inc. | -4.23 Billion USD | 86.572% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1235.887% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -8849.811% |
| Molecular Templates, Inc. | -10.46 Million USD | -5338.639% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -746.57% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -51.086% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -297.184% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -994.778% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -268.319% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -173.487% |
| MacroGenics, Inc. | -168.24 Million USD | -238.323% |
| RenovoRx, Inc. | -11.39 Million USD | -4894.805% |
| Adicet Bio, Inc. | -152.03 Million USD | -274.385% |
| Prime Medicine, Inc. | -191.29 Million USD | -197.56% |
| Aditxt, Inc. | -26.06 Million USD | -2084.018% |
| Adagene Inc. | -23.71 Million USD | -2299.71% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7686.599% |
| Quantum-Si incorporated | -111.17 Million USD | -412.011% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1698.559% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3804.631% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 566.51% |
| SciSparc Ltd. | -5.77 Million USD | -9759.83% |
| Vericel Corporation | -6.46 Million USD | -8705.817% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -6475.374% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2362.017% |
| Generation Bio Co. | -138.56 Million USD | -310.794% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -585.545% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -558.348% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -136.087% |
| Invivyd, Inc. | -207.78 Million USD | -173.943% |
| Relay Therapeutics, Inc. | -373 Million USD | -52.603% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -5969.284% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2749.821% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -5433.275% |
| 2seventy bio, Inc. | -216.7 Million USD | -162.667% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2731.324% |
| Clene Inc. | -40.54 Million USD | -1304.065% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -2264.031% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -938.777% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2028.442% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -62.603% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1449.624% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3640.511% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -448.888% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1574.043% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -234.282% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 16.82% |
| Evaxion Biotech A/S | -22.19 Million USD | -2464.347% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -590.937% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -155.108% |
| Trevena, Inc. | -35.28 Million USD | -1513.036% |
| Surrozen, Inc. | -45.78 Million USD | -1143.355% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -611.999% |
| Cingulate Inc. | -22.75 Million USD | -2401.003% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 7697.544% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1174.337% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -6812.947% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -455.011% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -675.71% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -816.983% |
| Clearmind Medicine Inc. | -8.74 Million USD | -6411.671% |
| Kronos Bio, Inc. | -121.83 Million USD | -367.215% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -647.031% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -19307.123% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -464.539% |
| Statera Biopharma, Inc. | -98.34 Million USD | -478.794% |
| ImmunityBio, Inc. | -362.25 Million USD | -57.131% |
| Korro Bio, Inc. | -84.53 Million USD | -573.348% |
| Kineta, Inc. | -15.72 Million USD | -3520.225% |
| BioVie Inc. | -32.17 Million USD | -1668.848% |
| Codexis, Inc. | -68.06 Million USD | -736.222% |
| Celularity Inc. | -192.28 Million USD | -196.02% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -155.7% |
| Celcuity Inc. | -66.23 Million USD | -759.437% |
| Virax Biolabs Group Limited | -6.49 Million USD | -8661.8% |
| Cibus, Inc. | -318.88 Million USD | -78.501% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1223.74% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1581.858% |
| IN8bio, Inc. | -30.33 Million USD | -1776.283% |
| Kodiak Sciences Inc. | -277.32 Million USD | -105.252% |
| Annexon, Inc. | -143.72 Million USD | -296.045% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -359.814% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -780.5% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2327.947% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -60.916% |
| Eyenovia, Inc. | -25.4 Million USD | -2140.408% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1843.897% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -10133.873% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -619.305% |
| Arcellx, Inc. | -89.88 Million USD | -533.298% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1153.431% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -314.853% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1729.721% |
| Moolec Science SA | -6.65 Million USD | -8454.624% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -831.022% |
| Geron Corporation | -193.94 Million USD | -193.491% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1215.997% |
| Royalty Pharma plc | 1.49 Billion USD | 138.147% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -246.736% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -6002.232% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2499.757% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -232.954% |
| Humacyte, Inc. | -100.04 Million USD | -468.941% |
| Structure Therapeutics Inc. | -102.77 Million USD | -453.839% |
| 89bio, Inc. | -151.2 Million USD | -276.45% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -610.338% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3814.773% |
| Genelux Corporation | -24.16 Million USD | -2255.506% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1577.941% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -231.417% |
| Notable Labs, Ltd. | -14.65 Million USD | -3783.523% |
| Liquidia Corporation | -73.38 Million USD | -675.657% |
| Mustang Bio, Inc. | -50.72 Million USD | -1022.123% |
| Immunovant, Inc. | -282.7 Million USD | -101.341% |
| Quantum-Si incorporated | -111.17 Million USD | -412.011% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -628.791% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2576.485% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -457.981% |
| Acasti Pharma Inc. | -11.31 Million USD | -4931.895% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2383.336% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3462.145% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -165.918% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -15413.678% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3483.079% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1852.217% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1275.43% |
| PepGen Inc. | -84.76 Million USD | -571.505% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1820.988% |
| United Therapeutics Corporation | 1.18 Billion USD | 148.038% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2385.95% |
| Solid Biosciences Inc. | -104.31 Million USD | -445.663% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1634.961% |
| Immuneering Corporation | -58.41 Million USD | -874.456% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -11082.35% |
| Silo Pharma, Inc. | -3.85 Million USD | -14663.18% |
| Belite Bio, Inc | -31.66 Million USD | -1697.423% |
| XOMA Corporation | -41.84 Million USD | -1260.18% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -743.021% |
| Bionomics Limited | -17.89 Billion USD | 96.819% |
| Apogee Therapeutics, Inc. | -93 Million USD | -512.032% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1695.314% |
| uniQure N.V. | -282.87 Million USD | -101.225% |
| Cassava Sciences, Inc. | -105.95 Million USD | -437.207% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7686.599% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -339.529% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1652.164% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -6750.701% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1836.411% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -10133.873% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3905.686% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -6303.51% |
| Altimmune, Inc. | -95.92 Million USD | -493.364% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -674.496% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1695.314% |
| Compugen Ltd. | -12.99 Million USD | -4281.219% |
| Peak Bio, Inc. | -1356.23 USD | -41969772.367% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -1047.504% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2430.938% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -134.916% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1813.561% |
| Zura Bio Limited | -62.63 Million USD | -808.726% |
| PolyPid Ltd. | -22.86 Million USD | -2389.212% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -3397.223% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1813.561% |
| Instil Bio, Inc. | -159.16 Million USD | -257.612% |
| argenx SE | -425.04 Million USD | -33.916% |
| Immunome, Inc. | -109.53 Million USD | -419.682% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -1030.211% |
| Verona Pharma plc | -67.83 Million USD | -739.157% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -2084.221% |
| Shattuck Labs, Inc. | -91.95 Million USD | -518.994% |
| CervoMed Inc. | -7.81 Million USD | -7185.494% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -678.564% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -4173.013% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1081.567% |
| Moolec Science SA | -6.65 Million USD | -8454.624% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -3360.559% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -320.929% |
| AnaptysBio, Inc. | -164.41 Million USD | -246.21% |
| Design Therapeutics, Inc. | -78.19 Million USD | -627.981% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -553.954% |
| NeurAxis, Inc. | -6.66 Million USD | -8440.902% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1305.487% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1454.618% |
| Achilles Therapeutics plc | -75.25 Million USD | -656.372% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -2084.221% |
| 180 Life Sciences Corp. | -13.47 Million USD | -4123.395% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 11139.055% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -19307.123% |
| Nutriband Inc. | -4.87 Million USD | -11583.429% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -413.818% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -926.543% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -1019.695% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -761.145% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -951.691% |
| Palisade Bio, Inc. | -13.07 Million USD | -4255.073% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1153.514% |
| Beam Therapeutics Inc. | -176.48 Million USD | -222.525% |
| Neurogene Inc. | -55.58 Million USD | -924.069% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -421.472% |
| AEON Biopharma, Inc. | -48.42 Million USD | -1075.345% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -488.572% |
| Sesen Bio, Inc. | -25.9 Million USD | -2096.951% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -581.45% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -4422.227% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -23.591% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -685.776% |
| Athira Pharma, Inc. | -125.46 Million USD | -353.675% |
| Vaccinex, Inc. | -22.88 Million USD | -2387.254% |
| HCW Biologics Inc. | -25.71 Million USD | -2113.339% |
| XOMA Corporation | -41.84 Million USD | -1260.18% |
| Nektar Therapeutics | -137.42 Million USD | -314.195% |
| Arvinas, Inc. | -401.5 Million USD | -41.77% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -6436698.247% |
| Merus N.V. | -156.54 Million USD | -263.602% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -467.726% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1544.159% |
| Rezolute, Inc. | -70.42 Million USD | -708.27% |
| Clene Inc. | -40.54 Million USD | -1304.065% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -3375.342% |
| BeyondSpring Inc. | -23.11 Million USD | -2362.611% |
| Synlogic, Inc. | -55.16 Million USD | -931.903% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -3074.789% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5158.758% |
| Peak Bio, Inc. | -1356.23 USD | -41969772.367% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1305.348% |
| Krystal Biotech, Inc. | -109.72 Million USD | -418.749% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -339.407% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -65.944% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -11893.545% |
| MannKind Corporation | 8.67 Million USD | 6659.207% |
| Ikena Oncology, Inc. | -75.41 Million USD | -654.748% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -5800.363% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -746.658% |
| Gossamer Bio, Inc. | -183.75 Million USD | -209.758% |
| CohBar, Inc. | -12.38 Million USD | -4494.724% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -1022.167% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1963.32% |
| Legend Biotech Corporation | -439.48 Million USD | -29.517% |
| Mural Oncology plc | -194.63 Million USD | -192.444% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -747.755% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3425.54% |
| Disc Medicine, Inc. | -91.12 Million USD | -524.645% |
| Champions Oncology, Inc. | -7.35 Million USD | -7638.01% |
| REGENXBIO Inc. | -268.12 Million USD | -112.29% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -5210.674% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -920.891% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1360.982% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -397.747% |
| Vaxart, Inc. | -83.34 Million USD | -582.938% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -6580.839% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1230.109% |
| Cellectis S.A. | -106.62 Million USD | -433.836% |
| Longeveron Inc. | -21.02 Million USD | -2606.776% |
| Repare Therapeutics Inc. | -116.22 Million USD | -389.751% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -112.531% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -652.473% |
| Revolution Medicines, Inc. | -487.18 Million USD | -16.836% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -8456.945% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1195.008% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -663.116% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -717.417% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -5069.449% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 113.214% |
| Denali Therapeutics Inc. | -196.69 Million USD | -189.38% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -6475.374% |
| Veru Inc. | -93.78 Million USD | -506.947% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2339.916% |
| Cingulate Inc. | -22.75 Million USD | -2401.003% |
| Passage Bio, Inc. | -108.38 Million USD | -425.153% |
| Context Therapeutics Inc. | -25.07 Million USD | -2170.238% |
| Exicure, Inc. | -14.99 Million USD | -3695.732% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -176.229% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1302.059% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -5757.895% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -208.753% |
| Nuvalent, Inc. | -149.49 Million USD | -280.762% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -6827.614% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -541.498% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2640.002% |
| OmniAb, Inc. | -69.41 Million USD | -719.96% |
| Anew Medical, Inc. | -1.3 Million USD | -43656.957% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -4357.035% |
| Lipocine Inc. | -17.93 Million USD | -3074.443% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -730.803% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -647.463% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1394.953% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1340.049% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2442.924% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 1.835% |
| Ocugen, Inc. | -65.53 Million USD | -768.609% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -506.405% |
| Q32 Bio Inc. | -92.1 Million USD | -518.019% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2555.012% |
| Alumis Inc. Common Stock | -158.17 Million USD | -259.862% |
| Equillium, Inc. | -14.52 Million USD | -3819.625% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -812.105% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -7102.111% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2917.253% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -1112.345% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -424.78% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -4655.282% |
| Dominari Holdings Inc. | -21.79 Million USD | -2511.525% |
| Edesa Biotech, Inc. | -9.22 Million USD | -6071.776% |
| vTv Therapeutics Inc. | -25.5 Million USD | -2132.013% |
| Bio-Techne Corporation | 206.68 Million USD | 375.397% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -45.396% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 396.416% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -330.315% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1382.66% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -276.707% |
| Nkarta, Inc. | -131.65 Million USD | -332.365% |
| BioCardia, Inc. | -11.64 Million USD | -4788.423% |
| Iterum Therapeutics plc | -47.46 Million USD | -1099.14% |